Jul 01, 2026
15 MIN READ

Is a Runny Nose a Side Effect of Ozempic?

A runny nose during GLP-1 therapy raises questions about whether the medication itself causes nasal symptoms or if other factors are at play. Understanding the connection between semaglutide and rhinitis helps you distinguish expected effects from genuine concerns.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jul 01, 2026
15 MIN READ

is a runny nose a side effect of ozempic? — PlexusDx GLP-1 education

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Runny nose and nasal congestion are not listed as common side effects in clinical trials of semaglutide, yet some patients report these symptoms during GLP-1 treatment. The question of whether a runny nose stems directly from the medication or from underlying metabolic shifts requires careful examination of both trial data and real-world experience.

Is Runny Nose a Known Ozempic Side Effect?

Clinical trials of semaglutide (the active ingredient in Ozempic) did not report runny nose or rhinitis as primary adverse events. The most frequently documented side effects centered on gastrointestinal symptoms—nausea, vomiting, and constipation—which affected between 25% and 60% of participants depending on dose and study design. Nasal symptoms were not flagged as a safety signal during Phase 3 testing.

However, the absence of a symptom from official trial reports does not mean it cannot occur in individual patients. Post-marketing surveillance and patient reports sometimes reveal side effects that emerge at lower frequencies or in specific populations. A runny nose during semaglutide treatment warrants honest dialogue with your healthcare provider to rule out coincidental illness or other contributing factors.

How GLP-1 Medications May Affect Nasal Function

GLP-1 receptor agonists influence more than appetite regulation—they activate receptors throughout the body, including in immune and inflammatory pathways. Some researchers theorize that rapid metabolic shifts from effective weight loss could temporarily alter mucus production or nasal blood flow, though direct evidence remains limited. Additionally, dehydration from gastrointestinal side effects might concentrate nasal secretions, creating a sensation of congestion or increased drainage.

The vagus nerve, which carries GLP-1 signals related to satiety, also innervates nasal tissues and the sinuses. Changes in vagal signaling could theoretically influence nasal inflammation or mucus clearance, but this mechanism has not been formally studied in the context of semaglutide treatment. Most nasal symptoms reported by patients appear mild and transient rather than persistent or severe.

Common Causes of Runny Nose During Weight Loss Treatment

Viral or bacterial upper respiratory infections remain the most likely culprit if a runny nose develops during GLP-1 therapy. Coincidental timing with semaglutide initiation does not prove causation. Seasonal allergies, environmental irritants, and sinus drainage from postnasal drip are equally common explanations that have nothing to do with the medication itself.

Dehydration is a frequently overlooked cause of nasal symptoms in patients taking GLP-1 drugs. Nausea and reduced fluid intake can lower overall hydration, which makes nasal mucosa drier and triggers reactive congestion or excessive drainage as the body attempts to restore moisture. Drinking adequate water and electrolyte-containing fluids often resolves these symptoms without stopping treatment.

When to Report Nasal Symptoms to Your Healthcare Provider

Contact your prescriber promptly if a runny nose is severe, persistent beyond two weeks, accompanied by fever or facial pain, or if it worsens despite treating dehydration and environmental allergies. These signs may indicate a sinus infection or other condition unrelated to semaglutide that requires separate medical attention. Your provider can evaluate your symptom timeline, examine whether the symptom correlates with dose changes, and recommend appropriate next steps.

If nasal symptoms are mild and resolved within a few days, they are unlikely to be medication-related and do not require stopping treatment. PlexusDx recommends open communication with your healthcare team about any concerns, especially when starting a new medication. Keeping a symptom diary helps you and your provider identify patterns and distinguish coincidental illness from actual side effects.

Personalized GLP-1 Therapy and Side Effect Prediction at PlexusDx

PlexusDx offers compounded semaglutide injections starting at $149 per month, allowing patients to access effective GLP-1 therapy without the high cost of brand-name Ozempic. All medications come from licensed 503A compounding pharmacies and are available in all 50 states with no insurance requirement or membership fee. HSA and FSA accounts are eligible for payment, making treatment accessible to more patients.

The Precision Peptide Genetic Test ($99 add-on after your first month) examines 14 metabolic pathways and 150+ genetic insights to predict how your body responds to GLP-1 compounds. Testing identifies variations in genes like GLP1R and GIPR that influence semaglutide efficacy and tolerability. This personalized approach helps your provider anticipate which side effects you may experience and optimize your therapy before problems arise.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can Ozempic or semaglutide cause a runny nose?

Runny nose is not a documented side effect in clinical trials of semaglutide, though individual cases have been reported anecdotally. Most likely explanations include coincidental viral infection, allergies, or dehydration from gastrointestinal side effects. If your runny nose persists or worsens, contact your healthcare provider to rule out unrelated conditions.

What does the clinical evidence say about GLP-1 and nasal symptoms?

Phase 3 trials of semaglutide focused on gastrointestinal, cardiovascular, and metabolic outcomes; nasal or respiratory symptoms were not identified as safety signals. The most common side effects involved nausea and constipation. Limited research exists on the relationship between GLP-1 activation and nasal inflammation, so connections remain theoretical rather than proven.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, with pricing flat across all dose levels—your dose may need to go up, but your price won't. Available in all 50 states, no insurance required, and HSA/FSA eligible. Licensed 503A compounding pharmacies ensure quality and safety.

Could dehydration from nausea be causing nasal congestion?

Yes, dehydration is a common culprit. GLP-1 medications can trigger nausea, which reduces fluid intake and dries out nasal tissues, triggering reactive congestion or excess mucus production. Drinking more water and electrolyte beverages often resolves nasal symptoms without stopping treatment.

How does the PlexusDx Precision Peptide Genetic Test help with side effects?

The test analyzes 14 metabolic pathways and examines genetic variants in GLP1R, GIPR, FTO, and MC4R genes to predict how your body tolerates semaglutide. At $99 after your first month of treatment, it provides 150+ personalized insights that help your provider optimize dosing and anticipate potential side effects before they occur.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves